Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

P. Soelberg Sørensen; C. Ross; K.M. Clemmensen; K. Bendtzen; J.L. Frederiksen; K. Jensen; O. Kristensen; T. Petersen; S. Rasmussen; M. Ravnborg; Egon Stenager; N. Koch-Henriksen

doi:10.1016/S0140-6736(03)14541-2

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

P. Soelberg Sørensen
, C. Ross
, K.M. Clemmensen
, K. Bendtzen
, J.L. Frederiksen
, K. Jensen
, O. Kristensen
, T. Petersen
, S. Rasmussen
, M. Ravnborg
, Egon Stenager
, N. Koch-Henriksen

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	The Lancet
Vol/bind	362
Udgave nummer	9391
Sider (fra-til)	1184-91
ISSN	0140-6736
DOI	https://doi.org/10.1016/S0140-6736(03)14541-2
Status	Udgivet - 2003

Dokumenter og links

10.1016/S0140-6736(03)14541-2

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

Soelberg Sørensen, P., Ross, C., Clemmensen, K. M., Bendtzen, K., Frederiksen, J. L., Jensen, K., Kristensen, O., Petersen, T., Rasmussen, S., Ravnborg, M., Stenager, E., & Koch-Henriksen, N. (2003). Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis. The Lancet, 362(9391), 1184-91. https://doi.org/10.1016/S0140-6736(03)14541-2

@article{29959b006fd111db81a9000ea68e967b,

title = "Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis",

author = "\{Soelberg S{\o}rensen\}, P. and C. Ross and K.M. Clemmensen and K. Bendtzen and J.L. Frederiksen and K. Jensen and O. Kristensen and T. Petersen and S. Rasmussen and M. Ravnborg and Egon Stenager and N. Koch-Henriksen",

year = "2003",

doi = "10.1016/S0140-6736(03)14541-2",

language = "English",

volume = "362",

pages = "1184--91",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier",

number = "9391",

}

Soelberg Sørensen, P, Ross, C, Clemmensen, KM, Bendtzen, K, Frederiksen, JL, Jensen, K, Kristensen, O, Petersen, T, Rasmussen, S, Ravnborg, M, Stenager, E & Koch-Henriksen, N 2003, 'Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis', The Lancet, bind 362, nr. 9391, s. 1184-91. https://doi.org/10.1016/S0140-6736(03)14541-2

TY - JOUR

T1 - Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

AU - Soelberg Sørensen, P.

AU - Ross, C.

AU - Clemmensen, K.M.

AU - Bendtzen, K.

AU - Frederiksen, J.L.

AU - Jensen, K.

AU - Kristensen, O.

AU - Petersen, T.

AU - Rasmussen, S.

AU - Ravnborg, M.

AU - Stenager, Egon

AU - Koch-Henriksen, N.

PY - 2003

Y1 - 2003

U2 - 10.1016/S0140-6736(03)14541-2

DO - 10.1016/S0140-6736(03)14541-2

M3 - Journal article

SN - 0140-6736

VL - 362

SP - 1184

EP - 1191

JO - The Lancet

JF - The Lancet

IS - 9391

ER -